Antiretroviral therapy has improved longevity for HIV-infected persons, but long-term HIV
infection is now complicated by increased rates of chronic medical conditions including …

Background People living with human immunodeficiency virus (HIV; PLWH) have a
markedly elevated anal cancer risk, largely due to loss of immunoregulatory control of …

Background. The incidence of non-Hodgkin lymphoma (NHL) in human immunodeficiency
virus (HIV)–infected patients remains high despite treatment with antiretroviral therapy …

Cancer and HIV are inextricably linked. Although the advent of antiretroviral therapy has led
to a marked decline in the incidence of malignancies classically linked to …

BACKGROUND: Hepatocellular carcinoma (HCC) is a concern among individuals with
human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome …

Incidence of noncommunicable diseases (NCDs), including cardiovascular disease (CVD),
cirrhosis, and non-AIDS-defining cancers (NADCs), have been associated with HIV viremia …

Objectives To assess the efficacy of topical 80% trichloroacetic acid (TCA) to treat internal
anal high-grade squamous intraepithelial lesions (HSILs) in HIV-positive individuals …

Background: Kaposi sarcoma (KS) remains common among HIV-infected persons. To better
understand KS etiology and to help target prevention efforts, we comprehensively examined …

Purpose of review The introduction of antiretroviral therapy (ART) has revolutionized HIV
infection management, resulting in improved outcomes and survival for people living with …

Malignancies represent a major cause of morbidity and mortality in human
immunodeficiency virus (HIV)-infected patients. The introduction of combined antiretroviral …